Socialiya - Entertainment. Knowledge. Community.
IBCFS With Prosigna-Guided Adjuvant Therapy Is Noninferior to Chemoendocrine Therapy in ER+/HER2– Early Breast Cancer

Adjuvant treatment directed by the 50-gene Prosigna assay was noninferior to standard chemotherapy f...

HEALTH NEWS May 30, 2026

IBCFS With Prosigna-Guided Adjuvant Therapy Is Noninferior to Chemoendocrine Therapy in ER+/HER2– Early Breast Cancer

Adjuvant treatment directed by the 50-gene Prosigna assay was noninferior to standard chemotherapy followed by endocrine therapy for invasive breast...

5 views 0 likes 0 comments
Share:
Adjuvant treatment directed by the 50-gene Prosigna assay was noninferior to standard chemotherapy followed by endocrine therapy for invasive breast...

Author: OncLive

Read Original Article

Related News

Advertisement
socialiya
Advertisement

Top Categories

Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya
Advertisement
socialiya